期刊
CANCER & METABOLISM
卷 8, 期 1, 页码 -出版社
BMC
DOI: 10.1186/s40170-020-00218-5
关键词
Pyrimidine ribonucleotide metabolism; Cancer therapy; CAD; DHODH; UMPS; Nucleoside transporters; CDA; CTPS; Therapeutic index
资金
- Swedish Research Council
- Swedish Cancer Society
- Swedish Childhood Cancer Foundation
- Karolinska Institute
By providing the necessary building blocks for nucleic acids and precursors for cell membrane synthesis, pyrimidine ribonucleotides are essential for cell growth and proliferation. Therefore, depleting pyrimidine ribonucleotide pools has long been considered as a strategy to reduce cancer cell growth. Here, we review the pharmacological approaches that have been employed to modulate pyrimidine ribonucleotide synthesis and degradation routes and discuss their potential use in cancer therapy. New developments in the treatment of myeloid malignancies with inhibitors of pyrimidine ribonucleotide synthesis justify revisiting the literature as well as discussing whether targeting this metabolic pathway can be effective and sufficiently selective for cancer cells to warrant an acceptable therapeutic index in patients.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据